VISUDYNE Side Effects

6346766-5 | Angle Closure Glaucoma, Choroidal Haemorrhage, Conjunctival Hyperaemia, Corneal Opacity, Epistaxis, Eye Pain, Flat Anterior Chamber Of Eye
on Aug 20, 2009 Female patient from SWITZERLAND , 78 years of age, was diagnosed with choroidal neovascularisation, cerebrovascular accident prophylaxis and was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: angle closure glaucoma, choroidal haemorrhage, conjunctival hyperaemia, corneal opacity, epistaxis, eye pain, flat anterior chamber of eye. Visudyne dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

6346765-3 | Product Quality Issue
Patient was taking Visudyne (View Usage). Patient had the following side effects: product quality issue on Aug 20, 2009 from CANADA Additional patient health information: Female patient , 85 years of age, . Visudyne dosage: . During the same period patient was treated with LUCENTIS (View Lucentis Review and Lucentis Label ).

6340262-7 | Ocular Hypertension
Adverse event was reported on Aug 17, 2009 by a Female patient taking Visudyne (View Usage) (Dosage: 2 Mg/m^2 Once Iv) . Location: ITALY , 73 years of age, After Visudyne was administered, patient had the following side effects: ocular hypertension. During the same period patient was treated with TRIAMCINOLONE ACETONIDE (25 Mg Dailty Ey) (View Triamcinolone Acetonide Review and Triamcinolone Acetonide Label ), POVIDONE IODINE (View Povidone Iodine Review and Povidone Iodine Label ), POLYMYXIN B SULFATE (View Polymyxin-b-sulfate Review and Polymyxin-b-sulfate Label ), NEOMYCIN SULFATE (View Neomycin Sulfate Review and Neomycin Sulfate Label ), TIMOLOL (View Timolol Review and Timolol Label ), FLUORESCEIN (View Fluorescein Review and Fluorescein Label ).

6340260-3 | Behcet's Syndrome, Capillary Disorder, Visual Acuity Reduced
on Aug 17, 2009 Male patient from CHINA , 43 years of age, was diagnosed with chorioretinopathy and was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: behcet's syndrome (What is behcet's syndrome?), capillary disorder, visual acuity reduced. Visudyne dosage: 3 Mg/m^2 Once Iv. During the same period patient was treated with FLUORESCEIN (View Fluorescein Review and Fluorescein Label ).


6340258-5 | Cataract Nuclear, Nipple Exudate Bloody
on Aug 11, 2009 Female patient from UNITED KINGDOM , 77 years of age, was treated with Visudyne (View Usage). Patient had the following side effects: cataract nuclear, nipple exudate bloody. Visudyne dosage: . During the same period patient was treated with ADCAL (View Adcal Review and Adcal Label ), EXEMESTANE (View Exemestane Review and Exemestane Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ERGOTAMINE (View Ergotamine Review and Ergotamine Label ).

6313872-0 | Maculopathy
Patient was taking Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: maculopathy on Jul 31, 2009 from JAPAN Additional patient health information: Male patient , 59 years of age, was diagnosed with polypoidal choroidal vasculopathy and. Visudyne dosage: .

6304682-9 | Thyroid Disorder
Adverse event was reported on Jul 22, 2009 by a Female patient taking Visudyne (View Usage) (Dosage: 15 Mg Once Iv) . Location: BRAZIL , 67 years of age, Patient experienced the following unwanted or unexpected effects: thyroid disorder. During the same period patient was treated with VITALUX PLUS (View Vitalux Plus Review and Vitalux Plus Label ).

6289150-5 | Haemorrhage, Pituitary Tumour
on Jul 13, 2009 Male patient from KOREA, REPUBLIC OF , 63 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with Visudyne (View Usage). Patient had the following side effects: haemorrhage, pituitary tumour. Visudyne dosage: .

6289149-9 | Atrophy, Visual Acuity Reduced, Vitreous Haemorrhage
on Jul 13, 2009 Female patient from KOREA, REPUBLIC OF , 54 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: atrophy, visual acuity reduced, vitreous haemorrhage. Visudyne dosage: .

6289141-4 | Retinal Exudates, Retinal Haemorrhage, Retinal Scar, Visual Acuity Reduced, Vitreous Haemorrhage
Patient was taking Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: retinal exudates, retinal haemorrhage, retinal scar, visual acuity reduced, vitreous haemorrhage on Jul 13, 2009 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 59 years of age, was diagnosed with polypoidal choroidal vasculopathy and. Visudyne dosage: .

6289139-6 | Condition Aggravated, Detachment Of Retinal Pigment Epithelium, Maculopathy, Polypoidal Choroidal Vasculopathy, Retinal Haemorrhage, Visual Acuity Reduced, Visual Impairment
Adverse event was reported on Jul 13, 2009 by a Male patient taking Visudyne (View Usage) (Dosage: ) was diagnosed with polypoidal choroidal vasculopathy and. Location: KOREA, REPUBLIC OF , 68 years of age, Patient had the following side effects: condition aggravated, detachment of retinal pigment epithelium, maculopathy, polypoidal choroidal vasculopathy, retinal haemorrhage, visual acuity reduced, visual impairment.

6255529-0 | Chorioretinal Disorder, Exudative Retinopathy, Visual Acuity Reduced
on Jun 15, 2009 Male patient from UNITED KINGDOM , 72 years of age, was diagnosed with choroidal neovascularisation and was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: chorioretinal disorder, exudative retinopathy, visual acuity reduced. Visudyne dosage: .

6243970-1 | Exudative Retinopathy, Macular Oedema, Photopsia, Polypoidal Choroidal Vasculopathy, Retinal Ischaemia, Retinal Vascular Disorder
on Jun 08, 2009 Female patient from UNITED STATES , 59 years of age, was diagnosed with chorioretinal disorder and was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: exudative retinopathy, macular oedema, photopsia, polypoidal choroidal vasculopathy, retinal ischaemia, retinal vascular disorder. Visudyne dosage: 6 Mg/m^2 Once Iv.

6237573-2 | Polypoidal Choroidal Vasculopathy, Visual Acuity Reduced
Patient was taking Visudyne (View Usage). Patient had the following side effects: polypoidal choroidal vasculopathy, visual acuity reduced on Jun 02, 2009 from UNITED STATES Additional patient health information: Male patient , 82 years of age, was diagnosed with choroidal neovascularisation, polypoidal choroidal vasculopathy and. Visudyne dosage: . During the same period patient was treated with LUCENTIS (View Lucentis Review and Lucentis Label ).

6235760-0 | Polypoidal Choroidal Vasculopathy
Adverse event was reported on Jun 02, 2009 by a Female patient taking Visudyne (View Usage) (Dosage: ) was diagnosed with choroidal neovascularisation and. Location: UNITED STATES , 80 years of age, After Visudyne was administered, patient had the following side effects: polypoidal choroidal vasculopathy.

6235756-9 | Polypoidal Choroidal Vasculopathy
on Jun 02, 2009 Male patient from UNITED STATES , 86 years of age, was diagnosed with choroidal neovascularisation and was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: polypoidal choroidal vasculopathy. Visudyne dosage: .

6235755-7 | Polypoidal Choroidal Vasculopathy
on Jun 02, 2009 Female patient from UNITED STATES , 70 years of age, was diagnosed with choroidal neovascularisation and was treated with Visudyne (View Usage). Patient had the following side effects: polypoidal choroidal vasculopathy. Visudyne dosage: . During the same period patient was treated with KENALOG (View Kenalog Review and Kenalog Label ).

6235754-5 | Polypoidal Choroidal Vasculopathy
Patient was taking Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: polypoidal choroidal vasculopathy on Jun 02, 2009 from UNITED STATES Additional patient health information: Female patient , 56 years of age, was diagnosed with choroidal neovascularisation and. Visudyne dosage: .

6235753-3 | Polypoidal Choroidal Vasculopathy
Adverse event was reported on Jun 02, 2009 by a Female patient taking Visudyne (View Usage) (Dosage: ) was diagnosed with choroidal neovascularisation and. Location: UNITED STATES , 75 years of age, Patient experienced the following unwanted or unexpected effects: polypoidal choroidal vasculopathy. During the same period patient was treated with KENALOG (View Kenalog Review and Kenalog Label ).

6235752-1 | Detachment Of Retinal Pigment Epithelium, Polypoidal Choroidal Vasculopathy, Retinal Deposits, Retinal Haemorrhage
on Jun 02, 2009 Male patient from UNITED STATES , 61 years of age, was diagnosed with retinal haemorrhage and was treated with Visudyne (View Usage). Patient had the following side effects: detachment of retinal pigment epithelium, polypoidal choroidal vasculopathy, retinal deposits, retinal haemorrhage. Visudyne dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), TRIAMCINOLONE (View Triamcinolone Review and Triamcinolone Label ).

6210031-7 | Retinal Oedema, Visual Acuity Reduced, Visual Field Defect
on May 20, 2009 Female patient from DENMARK , 79 years of age, was diagnosed with choroidal neovascularisation and was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: retinal oedema, visual acuity reduced, visual field defect. Visudyne dosage: 6 Mg/m^2 Once Iv. During the same period patient was treated with LUCENTIS (View Lucentis Review and Lucentis Label ).

6210028-7 | Diabetic Retinopathy, Macular Pseudohole, Ocular Vascular Disorder, Retinal Cyst, Visual Acuity Reduced, Vitreous Disorder
Patient was taking Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: diabetic retinopathy, macular pseudohole, ocular vascular disorder, retinal cyst, visual acuity reduced, vitreous disorder on May 20, 2009 from NETHERLANDS Additional patient health information: Female patient , 82 years of age, weighting 152.4 lb, was diagnosed with choroidal neovascularisation and. Visudyne dosage: . During the same period patient was treated with LUCENTIS (View Lucentis Review and Lucentis Label ).

6153639-X | Caesarean Section
Adverse event was reported on Mar 24, 2009 by a Female patient taking Visudyne (View Usage) (Dosage: 10.8 Mg Daily Iv) . Location: CHINA , 22 years of age, weighting 165.3 lb, Patient had the following side effects: caesarean section.

6140486-8 | Pain, Pulmonary Embolism
on Mar 17, 2009 Male patient from UNITED STATES , 69 years of age, weighting 178.0 lb, was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: pain (What is pain?), pulmonary embolism (What is pulmonary embolism?). Visudyne dosage: 5.7 Mg Daily Iv. Patient was hospitalized.

6099666-2 | Intraocular Pressure Increased, Retinal Artery Occlusion
on Feb 11, 2009 Male patient from AUSTRIA , 84 years of age, weighting 154.4 lb, was diagnosed with choroidal neovascularisation and was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: intraocular pressure increased, retinal artery occlusion. Visudyne dosage: . During the same period patient was treated with LUCENTIS (0.5 Mg Daily Ey) (View Lucentis Review and Lucentis Label ).

6071612-7 | Choroidal Neovascularisation, Disease Progression, Macular Oedema, Retinal Haemorrhage, Subretinal Fibrosis
Patient was taking Visudyne (View Usage). Patient had the following side effects: choroidal neovascularisation, disease progression, macular oedema, retinal haemorrhage, subretinal fibrosis on Jan 19, 2009 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with polypoidal choroidal vasculopathy and. Visudyne dosage: .

6064441-1 | Vision Blurred, Visual Acuity Reduced
Adverse event was reported on Jan 16, 2009 by a Male patient taking Visudyne (View Usage) (Dosage: ) . Location: UNITED STATES , 74 years of age, After Visudyne was administered, patient had the following side effects: vision blurred, visual acuity reduced.

6055084-4 | Chorioretinal Disorder, Corneal Scar, Glaucomatous Optic Disc Atrophy, Intraocular Pressure Increased, Off Label Use, Retinal Haemorrhage, Retinal Ischaemia, Retinal Oedema, Visual Acuity Reduced
on Jan 07, 2009 Female patient from POLAND , 75 years of age, weighting 149.9 lb, was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: chorioretinal disorder, corneal scar, glaucomatous optic disc atrophy, intraocular pressure increased, off label use, retinal haemorrhage, retinal ischaemia, retinal oedema, visual acuity reduced. Visudyne dosage: 5.1 Ml Once Iv. Patient was hospitalized.

6037821-8 | Anxiety, Discomfort, Headache, Malaise, Rash, Tachycardia, Tachypnoea
on Dec 30, 2008 Female patient from INDIA , 30 years of age, was diagnosed with chorioretinopathy and was treated with Visudyne (View Usage). Patient had the following side effects: anxiety (What is anxiety?), discomfort, headache (What is headache?), malaise, rash (What is rash?), tachycardia, tachypnoea. Visudyne dosage: 7 Mg/m^2 Daily Iv. During the same period patient was treated with STEROIDS (View Steroids Review and Steroids Label ), IMMUNOSUPPRESSANTS (View Immunosuppressants Review and Immunosuppressants Label ).

6037586-X | Retinal Injury, Retinal Ischaemia
Patient was taking Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: retinal injury, retinal ischaemia on Jan 05, 2009 from UNITED STATES Additional patient health information: Male patient , 83 years of age, . Visudyne dosage: .

6032702-8 | Retinal Vascular Disorder
Adverse event was reported on Dec 23, 2008 by a Male patient taking Visudyne (View Usage) (Dosage: ) . Location: UNITED STATES , 83 years of age, Patient experienced the following unwanted or unexpected effects: retinal vascular disorder.

6028270-7 | Retinal Exudates, Retinal Haemorrhage
on Dec 10, 2008 Male patient from JAPAN , 78 years of age, was diagnosed with choroidal neovascularisation, polypoidal choroidal vasculopathy and was treated with Visudyne (View Usage). Patient had the following side effects: retinal exudates, retinal haemorrhage. Visudyne dosage: .

6016881-4 | Anaphylactic Reaction
on Dec 10, 2008 Male patient from JAPAN , 67 years of age, was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: anaphylactic reaction. Visudyne dosage: . During the same period patient was treated with NU LOTAN (View Nu-lotan Review and Nu-lotan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FLIVAS (View Flivas Review and Flivas Label ), VASOMET (View Vasomet Review and Vasomet Label ).

6015506-1 | Bradycardia
Patient was taking Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia on Dec 03, 2008 from TURKEY Additional patient health information: Male patient , 70 years of age, . Visudyne dosage: .

6015497-3 | Retinal Exudates, Retinal Haemorrhage
Adverse event was reported on Dec 03, 2008 by a Male patient taking Visudyne (View Usage) (Dosage: ) was diagnosed with polypoidal choroidal vasculopathy and. Location: JAPAN , 78 years of age, Patient had the following side effects: retinal exudates, retinal haemorrhage.

6012709-7 | Choroidal Neovascularisation, Disease Progression, Macular Oedema, Retinal Haemorrhage, Subretinal Fibrosis, Visual Acuity Reduced
on Dec 02, 2008 Male patient from JAPAN , 76 years of age, was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: choroidal neovascularisation, disease progression, macular oedema, retinal haemorrhage, subretinal fibrosis, visual acuity reduced. Visudyne dosage: .

6012704-8 | Choroidal Neovascularisation, Disease Progression, Subretinal Fibrosis, Visual Acuity Reduced
on Dec 02, 2008 Female patient from JAPAN , 72 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: choroidal neovascularisation, disease progression, subretinal fibrosis, visual acuity reduced. Visudyne dosage: .

6000535-4 | Bradycardia
Patient was taking Visudyne (View Usage). Patient had the following side effects: bradycardia on Nov 27, 2008 from TURKEY Additional patient health information: Male patient , 70 years of age, . Visudyne dosage: .

5980054-1 | Eye Disorder, Retinal Vascular Disorder, Visual Acuity Reduced
Adverse event was reported on Nov 12, 2008 by a Male patient taking Visudyne (View Usage) (Dosage: ) was diagnosed with retinal vascular disorder and. Location: JAPAN , 77 years of age, After Visudyne was administered, patient had the following side effects: eye disorder, retinal vascular disorder, visual acuity reduced.

5980034-6 | Choroidal Neovascularisation, Macular Oedema, Retinal Haemorrhage, Subretinal Fibrosis, Visual Acuity Reduced
on Nov 12, 2008 Male patient from JAPAN , 76 years of age, was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: choroidal neovascularisation, macular oedema, retinal haemorrhage, subretinal fibrosis, visual acuity reduced. Visudyne dosage: .

5980033-4 | Choroidal Neovascularisation, Condition Aggravated, Subretinal Fibrosis, Visual Acuity Reduced
on Nov 12, 2008 Female patient from JAPAN , 72 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with Visudyne (View Usage). Patient had the following side effects: choroidal neovascularisation, condition aggravated, subretinal fibrosis, visual acuity reduced. Visudyne dosage: .

5980032-2 | Retinal Detachment, Retinal Pigment Epitheliopathy, Visual Acuity Reduced
Patient was taking Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: retinal detachment, retinal pigment epitheliopathy, visual acuity reduced on Nov 12, 2008 from ITALY Additional patient health information: Female patient , 51 years of age, was diagnosed with choroidal neovascularisation, myopia and. Visudyne dosage: . During the same period patient was treated with FLUORESCEIN (View Fluorescein Review and Fluorescein Label ).

5980028-0 | Retinal Disorder, Visual Acuity Reduced
Adverse event was reported on Nov 12, 2008 by a Male patient taking Visudyne (View Usage) (Dosage: ) was diagnosed with choroidal neovascularisation and. Location: ITALY , 36 years of age, Patient experienced the following unwanted or unexpected effects: retinal disorder (What is retinal disorder?), visual acuity reduced. During the same period patient was treated with FLUORESCEIN (View Fluorescein Review and Fluorescein Label ).

5980027-9 | Retinal Pigment Epitheliopathy, Visual Acuity Reduced
on Nov 12, 2008 Male patient from ITALY , 61 years of age, was diagnosed with choroidal neovascularisation, myopia and was treated with Visudyne (View Usage). Patient had the following side effects: retinal pigment epitheliopathy, visual acuity reduced. Visudyne dosage: . During the same period patient was treated with FLUORESCEIN (View Fluorescein Review and Fluorescein Label ).

5978845-6 | Macular Hole, Macular Oedema, Retinal Disorder, Retinal Haemorrhage
on Nov 12, 2008 Male patient from JAPAN , 59 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: macular hole, macular oedema, retinal disorder (What is retinal disorder?), retinal haemorrhage. Visudyne dosage: .

5963942-1 | Macular Hole
Patient was taking Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: macular hole on Nov 05, 2008 from JAPAN Additional patient health information: Male patient , 59 years of age, was diagnosed with polypoidal choroidal vasculopathy and. Visudyne dosage: .

5963941-X | Choroidal Neovascularisation, Macular Oedema, Retinal Haemorrhage, Subretinal Fibrosis, Visual Acuity Reduced
Adverse event was reported on Nov 05, 2008 by a Male patient taking Visudyne (View Usage) (Dosage: ) . Location: JAPAN , 76 years of age, Patient had the following side effects: choroidal neovascularisation, macular oedema, retinal haemorrhage, subretinal fibrosis, visual acuity reduced.

5963928-7 | Choroidal Neovascularisation, Subretinal Fibrosis, Visual Acuity Reduced
on Nov 05, 2008 Female patient from JAPAN , 72 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with Visudyne (View Usage). After Visudyne was administered, patient had the following side effects: choroidal neovascularisation, subretinal fibrosis, visual acuity reduced. Visudyne dosage: .

5940665-6 | Choroidal Neovascularisation, Condition Aggravated, Retinal Haemorrhage, Retinal Oedema, Visual Acuity Reduced
on Oct 14, 2008 Female patient from JAPAN , 41 years of age, was diagnosed with choroidal neovascularisation and was treated with Visudyne (View Usage). Patient experienced the following unwanted or unexpected effects: choroidal neovascularisation, condition aggravated, retinal haemorrhage, retinal oedema, visual acuity reduced. Visudyne dosage: 6 Mg/m^2 Daily Iv.

5934870-2 | Blister, Hyperaesthesia, Injection Site Extravasation, Injection Site Pain, Scab, Scar, Skin Exfoliation, Swelling
Patient was taking Visudyne (View Usage). Patient had the following side effects: blister, hyperaesthesia, injection site extravasation, injection site pain, scab (What is scab?), scar (What is scar?), skin exfoliation, swelling on Oct 10, 2008 from UNITED STATES Additional patient health information: Female patient , 68 years of age, . Visudyne dosage: . During the same period patient was treated with LUCENTIS (View Lucentis Review and Lucentis Label ), AVASTIN (View Avastin Review and Avastin Label ).